Showing results (101-110 of 492) with videos related to

Sort By:
Pageof 50
BMJ Open|May 28, 2016
Retrospective hepatitis C seroprevalence screening in the antenatal setting-should we be screening antenatal women?Chloe Orkin, Anna Jeffery-Smith, Graham R Foster, et al.
Bjpsych Open|July 28, 2022
Depression, anxiety, substance misuse and self-harm in children and young people with rare chronic liver diseaseWai Hoong Chang, Graham R Foster, Deirdre A Kelly, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|January 30, 2018
Ribavirin dose management in HCV patients receiving ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirinJordan J Feld, David E Bernstein, Ziad Younes, et al.
The Lancet. Infectious Diseases|January 6, 2024
Characterising the effectiveness of social determinants of health-focused hepatitis B interventions: a systematic reviewKikanwa Anyiwe, Aysegul Erman, Marian Hassan, et al.
Journal of Viral Hepatitis|October 16, 2020
Cost-effectiveness analysis of sofosbuvir and velpatasvir in chronic hepatitis C patients with decompensated cirrhosisJocelyn Chan, John J Kim, Brett K Barrett, et al.
Hepatology Communications|April 30, 2025
Hepatobiliary complications in patients with sickle cell disease: A 30-year review of 1009 patientsMaya Deeb, Kristel K Leung, Richard Ward, et al.
BMC Public Health|April 18, 2015
Illness perceptions and explanatory models of viral hepatitis B & C among immigrants and refugees: a narrative systematic reviewJohn A Owiti, Trisha Greenhalgh, Lorna Sweeney, et al.
Pharmacology & Therapeutics|April 10, 2012
Pharmacology and therapeutic potential of interferonsPeter M George, Rekha Badiger, William Alazawi, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 9, 2020
The emergency department as a setting-specific opportunity for population-based hepatitis C screening: An economic evaluationAndrew B Mendlowitz, David Naimark, William W L Wong, et al.
Pageof 50